Premenstrual disorders PMS
Conditions
Interventions
None listed
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
16 Years to 64 Years
Inclusion criteria
Inclusion criteria: For the observational prospective cohort study women must meet the following criteria: All participants must give signed informed consent. All participants must be of fertile age (16 years of age or older, with a maximum of 60 years). Participants must experience self-reported PMS or PMDD related symptoms. Participants must have a detectable cycle, which may either be a natural menstrual cycle or induced by hormonal contraceptives, of no longer than 40 days.
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from the observational prospective cohort study: Current pregnancy, or actively trying to conceive Insufficient proficiency in Dutch A potential subject who meets any of the following criteria will be excluded from the validation study: Current pregnancy, or actively trying to conceive Insufficient proficiency in Dutch Any current DSM-5 Axis 1 clinical disorder (other than PMDD) according to the SCID interview Current use of psychopharmaceutical medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter is PMM/PMDD symptomatology as assessed using the C-PASS questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary parameters are clinical diagnosis (SCID in validation study only), PMDD symptoms, co-morbid somatic and mental symptoms (GRSR, EPDS, PANAS, PQ-16, BSI-18, ADHD-screener, ASSIST-Lite), personality (DAPP-sf, HSP), quality of life (Q-LES-Q-SF), days of sick leave, disease course, medication use, service use, wellbeing, social functioning, psychiatric symptoms and history. | — |
Countries
Netherlands
Contacts
Public ContactA.M. Kamperman
Erasmus MC, Universitair Medisch Centrum Rotterdam
Outcome results
None listed